ÂÜÀòÂÒÂ×

Rachel Duthy has a strong background in immunology, microbiology, and pharmacology. With a PhD in Immunology from the University of Adelaide, Rachel has worked in various roles including Clinical Application & Partnership Manager at ZEISS Australia and New Zealand, Quality & Regulatory Affairs Manager at ZEISS Group, and Cancer Institute NSW Post-Doctoral Research Officer at Garvan Institute of Medical Research. Rachel's research has focused on the potential of dendritic cell fragments for tumour immunotherapy.